Clinical Outcomes After Week-12 Response-Guided Secukinumab Discontinuation in Psoriasis: A Prospective Real-World Cohort Study
- DOI
- 10.1007/s40259-026-00801-0
- Published
- 2026-08-03
- Container
- BioDrugs
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s40259-026-00801-0,
title = {Clinical Outcomes After Week-12 Response-Guided Secukinumab Discontinuation in Psoriasis: A Prospective Real-World Cohort Study},
author = {Xin Ma and Yue Jiang and Dongmei Liu and Quanruo Xu and Fanlingzi Shen and Zhen Duan and Xiangjin Gao and Xiuqi Zhang and Ruiqi Cai and Rui Zhang and Bin Li and Ruiping Wang},
year = {2026},
journal = {BioDrugs},
doi = {10.1007/s40259-026-00801-0},
url = {https://doi.org/10.1007/s40259-026-00801-0}
}RIS
TY - JOUR TI - Clinical Outcomes After Week-12 Response-Guided Secukinumab Discontinuation in Psoriasis: A Prospective Real-World Cohort Study AU - Xin Ma AU - Yue Jiang AU - Dongmei Liu AU - Quanruo Xu AU - Fanlingzi Shen AU - Zhen Duan AU - Xiangjin Gao AU - Xiuqi Zhang AU - Ruiqi Cai AU - Rui Zhang AU - Bin Li AU - Ruiping Wang PY - 2026 JO - BioDrugs DO - 10.1007/s40259-026-00801-0 UR - https://doi.org/10.1007/s40259-026-00801-0 ER -
APA
Ma, X., Jiang, Y., Liu, D., Xu, Q., Shen, F., Duan, Z., Gao, X., Zhang, X., Cai, R., Zhang, R., Li, B., & Wang, R. (2026). Clinical Outcomes After Week-12 Response-Guided Secukinumab Discontinuation in Psoriasis: A Prospective Real-World Cohort Study. BioDrugs. https://doi.org/10.1007/s40259-026-00801-0
Source records
- crossref · retrieved 2026-09-26T11:14:47.107Z